| 2026-04-14 | Australian Super Pty LtdUnternehmen | -96,88k | 615,72k | Verkauf | 6,36 | 95,20M | -0,10% |
| 2026-04-14 | Australian Super Pty LtdUnternehmen | 15,60M | 98,25M | Kauf | 6,30 | 95,20M | 19,60% |
| 2025-12-16 | Australian Super Pty LtdUnternehmen | 837,14k | 6,03M | Other Disposition | -7,20 | 79,69M | 1,06% |
| 2025-12-12 | Australian Super Pty LtdUnternehmen | 72,11M | 443,20M | Kauf | 6,15 | 79,69M | 950,22% |
| 2026-02-16 | L1 Capital Pty. LimitedUnternehmen | 3,78M | 24,33M | Kauf | 6,00 - 7,50 | 76,03M | 5,23% |
| 2026-02-11 | L1 Capital Pty. LimitedUnternehmen | -2,82M | 20,88M | Verkauf | 6,87 - 7,44 | 76,03M | -3,58% |
| 2026-02-27 | Mr. Dion J. WeislerIndependent Non-Executive Director | 10,75k | 75,36k | Kauf | 7,01 | 30,75k | 53,75% |
| 2026-03-06 | Mr. Dion J. WeislerIndependent Non-Executive Director | 12,49k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-02-27 | Dr. Nora Lia ScheinkestelIndependent Non-Executive Director | 5,02k | 35,23k | Kauf | 7,02 | 66,94k | 8,10% |
| 2026-02-27 | Ms. Belinda Jane HutchinsonIndependent Non-Executive Director | 3,53k | 0,00 | Derivative Exercise and Retained Stock | - | 88,67k | 4,14% |
| 2026-03-06 | Ms. Belinda Jane HutchinsonIndependent Non-Executive Director | 4,42k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-02-27 | Mr. John Patrick MullenIndependent Non-Executive Chairman | 7,84k | 0,00 | Derivative Exercise and Retained Stock | - | 99,97k | 8,51% |
| 2026-03-06 | Mr. John Patrick MullenIndependent Non-Executive Chairman | 9,83k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2026-02-10 | L1 Capital Pty. LimitedUnternehmen | -780,98k | 5,75M | Verkauf | 7,37 | 75,07M | -1,03% |
| 2025-10-03 | L1 Capital Pty. LimitedUnternehmen | 39,55M | 278,94M | Kauf | 6,93 - 7,08 | 75,85M | 108,94% |
| 2025-10-10 | L1 Capital Pty. LimitedUnternehmen | -241,12k | 1,69M | Verkauf | 6,42 - 7,26 | 75,85M | -0,32% |
| 2025-11-24 | Ms. Vanessa HudsonMD, Group CEO & Executive Director | 284,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-09-01 | Ms. Belinda Jane HutchinsonIndependent Non-Executive Director | 3,32k | 0,00 | Derivative Exercise and Retained Stock | - | 85,15k | 4,06% |
| 2025-09-05 | Ms. Belinda Jane HutchinsonIndependent Non-Executive Director | 3,53k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-09-01 | Mr. John Patrick MullenIndependent Non-Executive Chairman | 9,27k | 0,00 | Derivative Exercise and Retained Stock | - | 92,13k | 11,18% |
| 2025-09-05 | Mr. John Patrick MullenIndependent Non-Executive Chairman | 7,84k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | - | - | - |
| 2025-09-01 | Dr. Heather Joy SmithIndependent Non-Executive Director | 5,89k | 0,00 | Derivative Exercise and Retained Stock | - | 24,52k | 31,60% |
| 2025-08-29 | Dr. Nora Lia ScheinkestelIndependent Non-Executive Director | 2,11k | 16,17k | Kauf | 7,67 | 61,93k | 3,52% |
| 2025-09-05 | Ms. Vanessa HudsonMD, Group CEO & Executive Director | 223,50k | 0,00 | Derivative Exercise and Retained Stock | - | 1,29M | 20,97% |
| 2025-09-05 | Ms. Vanessa HudsonMD, Group CEO & Executive Director | 87,55k | 670,48k | Kauf | 7,66 | 1,29M | 7,28% |
| 2025-09-03 | Ms. Vanessa HudsonMD, Group CEO & Executive Director | -125,00k | 962,12k | Verkauf | 7,70 | 1,29M | -8,84% |
| 2025-08-01 | Mr. James Todd SampsonInsider | -1,13k | 0,00 | Other Derivative Disposition | - | - | - |